ICPE 2026 (42nd Annual Meeting)
Conference Focus
Pharmacoepidemiology, unlocking RWE to improve patient health
Overview
The 42nd International Conference on Pharmacoepidemiology (ICPE 2026) is the premier global event organized by the International Society for Pharmacoepidemiology (ISPE). It serves as a critical forum for researchers, regulators, and industry experts to discuss the latest advancements in drug safety, effectiveness, and the application of real-world evidence (RWE) to improve patient health outcomes. The conference is renowned for its rigorous scientific program, bridging the gap between academic research and practical industry application in pharmacovigilance. ICPE is unique for its multidisciplinary approach, fostering collaboration between epidemiologists, clinicians, and data scientists. It provides a platform to address complex challenges in post-marketing surveillance, benefit-risk assessment, and the evolving regulatory landscape, making it an essential event for those shaping the future of drug safety and therapeutic evaluation.
Why Attend
Pharma and biotech professionals should attend to gain actionable insights into the latest methodologies for RWE generation and safety signal detection. The conference offers unparalleled networking with global regulatory authorities and leading academic researchers. Attendees will learn to navigate complex safety reporting requirements, optimize clinical development strategies, and leverage data-driven approaches to demonstrate product value and ensure patient safety in a competitive market.
Key Topics & Sessions
- •Real-World Evidence (RWE) Generation
- •Post-Marketing Safety Surveillance
- •Benefit-Risk Assessment Methodologies
- •Pharmacoepidemiology in Regulatory Decision Making
- •Advanced Statistical Methods for Causal Inference
- •Drug Utilization Research
- •Patient-Reported Outcomes (PROs)
- •Artificial Intelligence in Pharmacovigilance
- •Vaccine Safety Monitoring
- •Comparative Effectiveness Research
Who Should Attend
Conference History
Organized by the International Society for Pharmacoepidemiology (ISPE), which was founded in 1989, the ICPE annual meeting has grown into the definitive global gathering for the field. Over four decades, it has evolved from a niche academic meeting into a major industry event that significantly influences international drug safety standards and regulatory policies.
Venue & Location
Allianz MiCo (Milano Convention Centre), Milan, Italy. A world-class facility located in the heart of one of Europe's leading business hubs.
Related Conference Categories
This conference covers topics in the following pharma and life sciences domains. Explore more events in each category using our conference directory filters.
Resources & Links
About the ICPE 2026 (42nd Annual Meeting) Conference
ICPE 2026 (42nd Annual Meeting) is a in-person event scheduled for 2026-08-29 to 2026-09-02 in Allianz MiCo, Milan, Italy. The conference focuses on pharmacoepidemiology, unlocking rwe to improve patient health. This event is categorized under Clinical Operations, Pharmacovigilance & Drug Safety in our conference directory.
The 42nd International Conference on Pharmacoepidemiology (ICPE 2026) is the premier global event organized by the International Society for Pharmacoepidemiology (ISPE). It serves as a critical forum for researchers, regulators, and industry experts to discuss the latest advancements in drug safety, effectiveness, and the application of real-world evidence (RWE) to improve patient health outcomes. The conference is renowned for its rigorous scientific program, bridging the gap between academic research and practical industry application in pharmacovigilance. ICPE is unique for its multidisciplinary approach, fostering collaboration between epidemiologists, clinicians, and data scientists. It provides a platform to address complex challenges in post-marketing surveillance, benefit-risk assessment, and the evolving regulatory landscape, making it an essential event for those shaping the future of drug safety and therapeutic evaluation.
Professionals attending conferences like ICPE 2026 (42nd Annual Meeting) gain access to cutting-edge insights, peer networking, and exposure to the latest technologies shaping the pharmaceutical and biotechnology sectors. Whether you are evaluating new vendors, seeking regulatory updates, or expanding your professional network, industry conferences remain one of the most effective ways to stay current in life sciences.
Looking for guidance on which conferences to attend or how to build your event strategy for 2026? Book a meeting with the IntuitionLabs team to discuss your priorities and how we can support your team.